Twist Bioscience Corporation
TWST
$25.31
-$0.30-1.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.33% | 0.52% | 4.13% | -2.01% | -5.17% |
| Total Depreciation and Amortization | -29.25% | -22.80% | -13.58% | 1.49% | 25.67% |
| Total Amortization of Deferred Charges | 188.89% | 188.89% | 188.89% | 188.89% | -- |
| Total Other Non-Cash Items | -84.78% | 88.96% | 92.64% | 188.95% | 68.69% |
| Change in Net Operating Assets | -139.80% | -87.74% | -39.92% | 1,627.35% | 1,480.65% |
| Cash from Operations | 26.40% | 35.14% | 43.84% | 55.01% | 43.53% |
| Capital Expenditure | -221.55% | -4.08% | 66.57% | 81.73% | 86.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.07% | -81.85% | -103.70% | -97.44% | -98.61% |
| Cash from Investing | -238.31% | -132.30% | -114.21% | -106.07% | -107.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 31.96% | 103.54% | 127.16% | 104.38% | 33.20% |
| Repurchase of Common Stock | 99.57% | 99.57% | 73.29% | 9.76% | -4.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 617.76% | 20,249.26% | 15,852.69% | 656.31% | 116.79% |
| Foreign Exchange rate Adjustments | 960.00% | 139.75% | 75.98% | 566.67% | 101.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.37% | 53.37% | 9.84% | 33.89% | -5.79% |